IP Group PLC — Director's Dealing 2025

Apr 9, 2025

National Storage Mechanism | Additional information

RNS Number : 2083E

IP Group PLC

09 April 2025

FOR RELEASE ON	09 April 2025

IP Group - Director/PDMR share purchases

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which invests in breakthrough science and innovation companies with the potential to create a better future for all, has been notified that on 07 April 2025, Greg Smith, Chief Executive Officer, purchased a total of 120,000 Shares of 2p each as outlined in the below table.

Name	Title	Number of shares acquired	Price per share	Resulting shareholding *	Resulting shareholding as a percentage of the Company's issued share capital
Greg Smith	Chief Executive Officer	120,000	35.4 p	872,686	0.1%

* Resulting shareholding excludes 122,328 shares that are subject to award under the Company's Long Term Incentive Plan which have vested by reference to performance conditions, but which remain subject to a holding period and thus have not yet been formally issued.

The notification below, made in accordance with the requirements of article 19 of the UK Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Greg Smith

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IP Group plc

b)

LEI

213800HG22UM138WFG43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

ISIN: GB00B128J450

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)	Volume(s)
35.2387 35.3889	29,577 90,423

d)

Aggregated information

-     Aggregated volume

-     Price

120,000

35.35 pence per share

e)

Date of the transaction

07 April 2025

f)

Place of the transaction

London Stock Exchange, Main Market

For more information, please contact:

IP Group plc	www.ipgroupplc.com
Liz Vaughan-Adams, Communications	+44 (0) 20 7444 0062/+44 (0) 7967 312125
Portland
Alex Donaldson	+44 (0) 7516 729702

Notes for editors

About IP Group

IP Group accelerates the impact of science for a better future. As the most active UK based, early stage science investor, we develop and support some of the world's most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxa. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO. For more information, please visit our website at www.ipgroupplc.com .

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHUPUBWCUPAGMR